Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

The Lancet

Volumn 345, Issue 8956, 1995, Pages 1008-1012

  Brem, H ^a   Piantadosi, S ^a,b   Burger, P C ^a   Walker, M ^c   Selker, R ^d   Vick, N A ^e   Black, K ^f   Sisti, M ^g   Brem, S ^h   Mohr, G ⁱ   Muller, P ^j   Morawetz, R ^k   Schold, S C ^l  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d WESTERN PENNSYLVANIA HOSPITAL   (United States)

^e EVANSTON HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Department of Neurology Evanston Hospital ^*  (United Kingdom)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ MCGILL UNIVERSITY   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARMUSTINE;

ADULT; ANEMIA; ARTICLE; BRAIN INFECTION; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOSURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG IMPLANT; DRUG IMPLANTATION; DRUG SAFETY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INTRATUMORAL DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEIZURE; THROMBOCYTOPENIA;

EID: 0028917333     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)90755-6     Document Type: Article

References (28)

1. Brain tumors
2. The value of reoperation for recurrent glioblastoma
3. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma
4. Polyanhydride microspheres as drug carriers. II Microencapsulation by solvent removal
5. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
6. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain
7. The intracerebral distribution of BCNU delivery by surgically implanted biodegradable polymers
8. Interstitial chemotherapy of the 9L ghosarcoma: controlled release polymers for drug delivery in the brain
9. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas
10. Polyanhydrides for controlled drug delivery
11. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme
12. Utility of postmortem magnetic resonance imaging in clinical neuropathology
13. Nonparametric estimation from incomplete observations
14. Statistical aspects of the analysis of data from retrospective studies of disease
15. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials
16. Selection bias, survival, and brachytherapy for glioma
17. Regression models and life tables (with discussion)
18. Phenytoin and postoperative epilepsy: a double-blind study
19. Wide variation in risk of wound infection following clean neurosurgery
20. Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study
21. Controlled release of a cyclophosphamide derivative with polymers is effective against rat gliomas
22. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma
23. Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema
24. Transforming growth factor alpha pseudomonas exotoxin fusion protein (TGF alpha-PE38) treatment of subcutaneous and intracranial human medulloblastoma and glioma xenografts in athymic mice
25. The role of minocycline in treatment of intracranial 9L glioma
26. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo